» Articles » PMID: 24195779

Integrating Multiple 'omics' Analyses Identifies Serological Protein Biomarkers for Preeclampsia

Overview
Journal BMC Med
Publisher Biomed Central
Specialty General Medicine
Date 2013 Nov 8
PMID 24195779
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Preeclampsia (PE) is a pregnancy-related vascular disorder which is the leading cause of maternal morbidity and mortality. We sought to identify novel serological protein markers to diagnose PE with a multi-'omics' based discovery approach.

Methods: Seven previous placental expression studies were combined for a multiplex analysis, and in parallel, two-dimensional gel electrophoresis was performed to compare serum proteomes in PE and control subjects. The combined biomarker candidates were validated with available ELISA assays using gestational age-matched PE (n=32) and control (n=32) samples. With the validated biomarkers, a genetic algorithm was then used to construct and optimize biomarker panels in PE assessment.

Results: In addition to the previously identified biomarkers, the angiogenic and antiangiogenic factors (soluble fms-like tyrosine kinase (sFlt-1) and placental growth factor (PIGF)), we found 3 up-regulated and 6 down-regulated biomakers in PE sera. Two optimal biomarker panels were developed for early and late onset PE assessment, respectively.

Conclusions: Both early and late onset PE diagnostic panels, constructed with our PE biomarkers, were superior over sFlt-1/PIGF ratio in PE discrimination. The functional significance of these PE biomarkers and their associated pathways were analyzed which may provide new insights into the pathogenesis of PE.

Citing Articles

Gestational Dating by Urine Metabolic Profile at High Resolution Weekly Sampling Timepoints: Discovery and Validation.

Sylvester K, Hao S, Li Z, Han Z, Tian L, Ladella S Front Mol Med. 2024; 2:844280.

PMID: 39086969 PMC: 11285704. DOI: 10.3389/fmmed.2022.844280.


Placenta: an old organ with new functions.

Khorami-Sarvestani S, Vanaki N, Shojaeian S, Zarnani K, Stensballe A, Jeddi-Tehrani M Front Immunol. 2024; 15:1385762.

PMID: 38707901 PMC: 11066266. DOI: 10.3389/fimmu.2024.1385762.


A comprehensive analysis of metabolomics and transcriptomics to reveal major metabolic pathways and potential biomarkers of human preeclampsia placenta.

Feng Y, Lian X, Guo K, Zhang G, Huang X Front Genet. 2022; 13:1010657.

PMID: 36263435 PMC: 9574103. DOI: 10.3389/fgene.2022.1010657.


Blood biomarkers representing maternal-fetal interface tissues used to predict early-and late-onset preeclampsia but not COVID-19 infection.

Sufriyana H, Salim H, Muhammad A, Wu Y, Su E Comput Struct Biotechnol J. 2022; 20:4206-4224.

PMID: 35966044 PMC: 9359600. DOI: 10.1016/j.csbj.2022.08.011.


Improving preeclampsia risk prediction by modeling pregnancy trajectories from routinely collected electronic medical record data.

Li S, Wang Z, Vieira L, Zheutlin A, Ru B, Schadt E NPJ Digit Med. 2022; 5(1):68.

PMID: 35668134 PMC: 9170686. DOI: 10.1038/s41746-022-00612-x.


References
1.
Wolf M, Shah A, Lam C, Martinez A, Smirnakis K, Epstein F . Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies. Am J Obstet Gynecol. 2005; 193(1):16-22. DOI: 10.1016/j.ajog.2005.03.016. View

2.
Bachmayer N, Hamad R, Liszka L, Bremme K, Sverremark-Ekstrom E . Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NK-cell promoting cytokine interleukin-12 in pre-eclampsia. Am J Reprod Immunol. 2006; 56(5-6):292-301. DOI: 10.1111/j.1600-0897.2006.00429.x. View

3.
Stepan H, Schaarschmidt W, Jank A, Verlohren S, Kratzsch J . [Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience]. Z Geburtshilfe Neonatol. 2011; 214(6):234-8. DOI: 10.1055/s-0030-1262827. View

4.
Ideker T, Thorsson V, Ranish J, Christmas R, Buhler J, Eng J . Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science. 2001; 292(5518):929-34. DOI: 10.1126/science.292.5518.929. View

5.
Sakai M, Shiozaki A, Sasaki Y, Yoneda S, Saito S . The ratio of interleukin (IL)-18 to IL-12 secreted by peripheral blood mononuclear cells is increased in normal pregnant subjects and decreased in pre-eclamptic patients. J Reprod Immunol. 2004; 61(2):133-43. DOI: 10.1016/j.jri.2004.01.001. View